Pubblicazioni Scientifiche
Dermatologia25 ott 2023
Guselkumab for the treatment of patients
Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that causes substantial physical
25 ott 2023
Exposure to biologic therapy
Biologicals have transformed the management of severe disease phenotypes in psoriasi
10 ott 2023
Stevens-johnson Syndrome and Toxic Epidermal Necrolysis
Both Stevens-Johnson syndrome (SJS) and Toxic-epidermal necrolysis
10 ott 2023
Autoimmune and Autoinflammatory Connective Tissue
Multiple cases of autoimmune and autoinflammatory diseases after COVID-19 have been reported
10 ott 2023
Impact of Baricitinib on Patients'
The efficacy and safety of baricitinib for treatment of atopic dermatitis have been demonstrated in clinical trials
29 set 2023
Utility of line-field confocal optical coherence
In the last decades diagnosis of dermatological diseases has achieved a significant progress with the aid of imaging technologies
29 set 2023
Efficacy and safeness of tralokinumab in patients with atopic dermatitis
Efficacy and safeness of tralokinumab in patients with atopic dermatitis who developed conjunctivitis under dupilumab: A case series
29 set 2023
Line-field confocal optical coherence tomography
Line-field confocal optical coherence tomography and reflectance confocal microscopy of Merkel cell carcinoma
14 set 2023
Therapeutic Outcomes and Survival Analysis of Extramammary
Evidence regarding long-term therapeutic outcomes and disease-specific survival (DSS) in Extramammary Paget's disease
14 set 2023
Real-World Clinical, Psychosocial, and Economic Burden of Atopic Dermatitis
Atopic dermatitis (AD), a relapsing, inflammatory skin disease, is associated with pruritus that can negatively affect patients’ quality of life
14 set 2023
Worldwide Differences in Clinical Management Practices of Scabies
Worldwide Differences in Clinical Management Practices of Scabies
31 ago 2023
Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib
Characterization of upadacitinib use and switching from dupilumab to upadacitinib among patients with moderate-to-severe atopic dermatitis (AD) is needed.
31 ago 2023
A Practical Algorithm for the Management of Superficial Folliculitis of the Scalp
Superficial folliculitis of the scalp (SFS) is a common complaint in clinical practice, and initial presentation may be difficult to differentiate as they may appear very similar to each other.
31 ago 2023
Is reflectance confocal microscopy useful in the differential diagnosis of extra facial lentigo maligna?
Extra facial lentigo maligna (EF-LM) arises outside the head and neck area. EF-LM presents the classic histological features of lentigo maligna.
04 ago 2023
Harald Kittler on learning model for AI
About paper "A reinforcement learning model for AI-based decision support in skin cancer"
01 ago 2023
Nipple eczema
The nipple is the focal point of the human breast and serves important physiological
01 ago 2023
Revealing The Unseen
In use for over a century, the Wood's lamp is a time-tested tool to aid in the diagnosis of certain superficial infections
01 ago 2023
Lebrikizumab for the Treatment
Atopic dermatitis (AD) is a common, heterogeneous, inflammatory skin disorder
28 lug 2023
Un modello di potenziamento dell'apprendimento per il supporto decisionale basato sull'IA nel cancro della pelle
Paper dello studio pubblicato su Nature Medicine il 27 luglio 2023
17 lug 2023
The differential effects of upadacitinib treatment on skin
Upadacitinib is an oral Janus kinase (JAK) 1 inhibitor approved in Japan for moderate-to-severe atopic dermatitis